Fluticasone Propionate Lotion
If you find any inaccurate information, please let us know by providing your feedback here

Tóm tắt nội dung
This article is compiled based on the United States Pharmacopeia (USP) – 2025 Edition
Issued and maintained by the United States Pharmacopeial Convention (USP)
1 DEFINITION
Fluticasone Propionate Lotion is fluticasone propionate in a suitable lotion base. It contains NLT 90.0% and NMT 110.0% of the labeled amount of fluticasone propionate (C25H31F3O5S).
2 IDENTIFICATION
A. The retention time of the major peak of the Sample solution corresponds to that of the Standard solution, as obtained in the Assay.
B. The UV spectrum of the major peak of the Sample solution corresponds to that of the Standard solution, as obtained in the Assay.
3 ASSAY
3.1 PROCEDURE
Buffer: 1.15 g/L of monobasic ammonium phosphate in water. Adjust with phosphoric acid to a pH of 3.5. Pass the solution through a suitable filter of 0.45-µm pore size.
Mobile phase: Acetonitrile, methanol, and Buffer (13:50:37)
Standard stock solution: 0.8 mg/mL of USP Fluticasone Propionate RS, prepared as follows. Transfer 40 mg of USP Fluticasone Propionate RS to a 50-mL volumetric flask. Add 10 mL of tetrahydrofuran and sonicate to dissolve. Dilute with methanol to volume.
Standard solution: 0.04 mg/mL of USP Fluticasone Propionate RS in methanol from Standard stock solution
Sample solution: Nominally 0.04 mg/mL of fluticasone propionate from Lotion, prepared as follows. Transfer a portion of Lotion to a suitable volumetric flask. Add tetrahydrofuran equivalent to about 20% of the flask volume and vortex until the Lotion is dispersed. Add methanol equivalent to 60% of the flask volume and sonicate for 10 min to dissolve. Dilute with methanol to volume. Pass a portion of the solution through a suitable filter of 0.45-µm pore size.
3.2 Chromatographic system
(See Chromatography (621), System Suitability.)
Mode: LC
Detector: 239 nm. For Identification B, use a diode array detector in the range of 200-400 nm.
Column: 4.6-mm × 25-cm; 5-µm packing L1
Column temperature: 45°
Flow rate: 1 mL/min
Injection volume: 20 µL
Run time: NLT 1.25 times the retention time of fluticasone propionate
3.3 System suitability
Sample: Standard solution
Suitability requirements
Tailing factor: NMT 2.0
Column efficiency: NLT 5000 theoretical plates
Relative standard deviation: NMT 2.0%
3.4 Analysis
Samples: Standard solution and Sample solution
Calculate the percentage of the labeled amount of fluticasone propionate (C25H31F3O5S) in the portion of Lotion taken:
Result = (rU/rS) x (CS/CU) x 100
rU = peak response of fluticasone propionate from the Sample solution
rS = peak response of fluticasone propionate from the Standard solution
CS = concentration of USP Fluticasone Propionate RS in the Standard solution (mg/mL)
CU = nominal concentration of fluticasone propionate in the Sample solution (mg/mL)
Acceptance criteria: 90.0%-110.0%
4 PERFORMANCE TESTS
MINIMUM FILL (755): Meets the requirements
5 IMPURITIES
5.1 ORGANIC IMPURITIES
Solution A: Methanol, phosphoric acid, and water (30:0.5:970)
Solution B: Acetonitrile, methanol, and phosphoric acid (950:50:0.5)
Mobile phase: See Table 1.
Table 1
| Time (min) | Solution A (%) | Solution B (%) |
| 0 | 56 | 44 |
| 45 | 56 | 44 |
| 49 | 10 | 90 |
| 70 | 10 | 90 |
| 71 | 56 | 44 |
| 80 | 56 | 44 |
System suitability solution: 0.13 mg/mL of USP Fluticasone Propionate RS and 0.38 µg/mL of USP Fluticasone Propionate Related Compound D RS in methanol
Standard stock solution: 0.25 mg/mL of USP Fluticasone Propionate RS, prepared as follows. Transfer 25 mg of USP Fluticasone Propionate RS to a 100-mL volumetric flask. Add 25 mL of tetrahydrofuran and sonicate to dissolve. Dilute with methanol to volume.
Standard solution: 0.63 µg/mL of USP Fluticasone Propionate RS in methanol from Standard stock solution
Sample solution: Nominally 0.13 mg/mL of fluticasone propionate from Lotion, prepared as follows. Transfer a portion of Lotion, equivalent to 1.25 mg of fluticasone propionate, to a suitable volumetric flask. Add tetrahydrofuran equivalent to 20% of the flask volume and vortex until the Lotion is dispersed. Add methanol equivalent to 40% of the flask volume and sonicate for 10 min to dissolve. Dilute with methanol to volume. Pass a portion of the solution through a suitable filter of 0.45-µm pore size.
5.2 Chromatographic system
(See Chromatography (621), System Suitability.)
Mode: LC
Detector: 239 nm
Column: 4.6-mm × 25-cm; 5-µm packing L1
Column temperature: 40°
Flow rate: 1.5 mL/min
Injection volume: 40 µL
5.3 System suitability
Samples: System suitability solution and Standard solution
[NOTE-See Table 2 for the relative retention times.]
Suitability requirements
Resolution: NLT 1.5 between fluticasone propionate related compound D and fluticasone propionate, System suitability solution
Relative standard deviation: NMT 5.0% from six replicate injections, Standard solution
5.4 Analysis
Samples: Standard solution and Sample solution
Calculate the percentage of fluticasone propionate related compound C, fluticasone propionate related compound D, or any individual unspecified degradation product in the portion of Lotion taken:
Result = (rU/rS) x (CS/CU) x (1/F) x 100
rU = peak response of fluticasone propionate related compound C, fluticasone propionate related compound D, or each unspecified degradation product from the Sample solution
rS = peak response of fluticasone propionate from the Standard solution
CS = concentration of USP Fluticasone Propionate RS in the Standard solution (µg/mL)
CU = nominal concentration of fluticasone propionate in the Sample solution (µg/mL)
F = relative response factor (see Table 2)
Acceptance criteria: See Table 2.
Table 2
| Name | Relative Retention Time | Relative Response Factor | Acceptance Criteria, NMT (%) |
| Fluticasone propionate related compound Ca | 0.67 | 0.82 | 0.10 |
| Fluticasone propionate related compound D | 0.91 | 1.1 | 0.30 |
| Fluticasone propionate | 1.0 | 1.0 | — |
| Any unspecied degradation product | — | 1.0 | 0.10 |
| Total degradation products | — | — | 1.0 |
a S-Fluoromethyl 17α-acetyloxy-6α, 9α-difluoro-11β-hydroxy-16α-methyl-3-oxoandrosta-1,4-diene-17β-carbothioate.
6 SPECIFIC TESTS
6.1 PH (791)
Sample: 50 mg/mL of Lotion in water
Acceptance criteria: 4.0-6.0
6.2 MICROBIAL ENUMERATION TESTS (61) and TESTS FOR SPECIFIED MICROORGANISMS (62)
Meets the requirements of the tests for absence of Salmonella species, Escherichia coli, Staphylococcus aureus, and Pseudomonas aeruginosa. The total aerobic microbial count is NMT 102 cfu/g, and the total combined molds and yeasts count is NMT 10 cfu/g.
7 ADDITIONAL REQUIREMENTS
7.1 PACKAGING AND STORAGE
Preserve in tight containers. Store at controlled room temperature. Do not refrigerate.
7.2 USP REFERENCE STANDARDS (11)
USP Fluticasone Propionate RS
USP Fluticasone Propionate Related Compound D RS
S-Methyl 6α,9α-difluoro-11β-hydroxy-16α-methyl-3-oxo-17α-propionyloxyandrosta-1,4-diene-17β-carbothioate.
C25H32F2O5S 482.58

